Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ · Manufacturing · Pharmaceutical preparations
ACXP price, last 12 months
Key stats
- Previous close
- $1.00
- Open
- $1.03
- Day range
- $1.03 – $1.11
- 52-week range
- $0.9000 – $7.54
- Volume
- 132K
- Avg volume (20 days)
- 119.9K
- Market cap
- $5.3M
Performance
Technicals and fundamentals
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $5.3M